Greetings, welcome to the April issue of the Device Discourse.
As more people start to receive their COVID-19 vaccinations, I’m optimistic that business is starting to return to normal.
This month, we’re highlighting regulatory updates to ethylene oxide (EO) sterilization cycles. If you utilize EO sterilization for your medical device, let’s set up a discovery call to discuss revalidation of your sterilization cycle.
After a relatively quiet year due to the pandemic, the medtech market is bouncing back with cash and a flurry of mergers and acquisitions.
As you ramp up to get your product to market, don’t overlook the importance of a quality-first approach. Learn how to prioritize quality assurance and regulatory compliance at every stage of the product life-cycle in our latest white paper, The MedTech Startup Guide to Quality.
What quality assurance, regulatory compliance, or microbiology and sterilization topics are keeping you up at night?
Maybe it’s time for a gap analysis to check on the health of your quality systems. We offer complimentary 30-minute discovery calls to help you identify potential hazards and areas for improvement.